Filing Details
- Accession Number:
- 0000880771-14-000025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-04 13:24:47
- Reporting Period:
- 2014-09-02
- Filing Date:
- 2014-09-04
- Accepted Time:
- 2014-09-04 13:24:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 880771 | Sciclone Pharmaceuticals Inc | SCLN | Pharmaceutical Preparations (2834) | 943116852 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1555794 | Lan Xie | Sciclone Pharmaceuticals, Inc 950 Tower Lane, Suite 900 Foster City CA 94404 | Vp Finance, China Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-09-02 | 31,468 | $5.19 | 31,468 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-02 | 31,468 | $6.97 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-09-02 | 5,000 | $4.53 | 5,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-02 | 5,000 | $6.97 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualifed Stock Option (right to buy) | Disposition | 2014-09-02 | 31,468 | $0.00 | 31,468 | $5.19 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-09-02 | 5,000 | $0.00 | 5,000 | $4.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 32,500 | 2022-08-01 | No | 4 | M | Direct | |
| 10,000 | 2023-04-04 | No | 4 | M | Direct |
Footnotes
- Granted under the Issuer's 2005 Equity Incentive Plan.
- 25% of such shares vest from the date of grant and 2.0833% vests each month thereafter, provided that the Reporting Person continues to be employed by the Issuer.
Billionaire Hedge Funds
